NAPPI® Circulars

MediKredit distributes circulars to the healthcare industry to notify stakeholders of any important information or changes relating to NAPPI® codes.

ReferenceSubjectEffective Date
N009/2023

Nappi Change in Number of Uses – Iso Clear

01/09/2023 Download
N008/2023

NAPPI Dosage form Change – Bayer Pty Ltd

29/08/2023 Download
N007/2023

NAPPI Change in Number of Uses – Respiratory Care Africa

20/07/2023 Download
N006/2023

NAPPI Change in Number of Uses – Mr First Aid

20/07/2023 Download
N005/2023

NAPPI change from Section 21 to SAHPRA Registered Product_Flucytosine mylan - Mylan (Pty) Ltd

26/05/2023 Download
N004/2023

NAPPI change from Section 21 Product to SAHPRA Registered Product

06/04/2023 Download
N003/2023

Involuntary Withdrawal of Products – Pholcodine Containing Medicines

03/04/2023 Download
N002/2023

Involuntary Withdrawal of Products- Pholcodine Containing Medicines

30/03/2023 Download
N001/2023

New NAPPI Code: Pfizer COVID-19 Paediatric Vaccine

01/02/2023 Download
N018/2022

MediKredit Head Office Physical Address Change

01/01/2023 Download
N017/2022

NAPPI Change from Section 21 to Registered Product – Takeda Pty Ltd

07/12/2022 Download
N016/2022

NAPPI Change in number of uses - Surgical Innovations  

08/11/2022 Download
N015/2022

NAPPI Change in Number of Uses – Iso Clear

08/11/2022 Download
N014/2022

NAPPI Change in Number of Uses- Johnson & Johnson Medical (Pty) Ltd-CSS

25/10/2022 Download
N013/2022

NAPPI Change from Section 21 to SAHPRA Registered  Product - Alecensa

11/08/2022 Download
N012/2022

NAPPI Change From Section 21 to SAHPRA Registered Product – Uptravi Range

20/07/2022 Download
N011/2022

Notification of NAPPI Code Changes – Barr Cocaine and Morphine Powders

15/07/2022 Download
N010/2022

Notification of NAPPI Change From SecNotification of NAPPI Change From Section 21 to SAHPRA Registered Product – Uptravi 1200 mcg TABtion 21 to SAHPRA Registered Product – Uptravi 1200 mcg TAB

01/07/2022 Download
N009/2022

Notification of NAPPI Change from Section 21 Products to SAHPRA Registered -  Imfinzi

27/06/2022 Download
N008/2022

NAPPI Change in Number of Uses – Selective Surgicals CC

22/06/2022 Download
N007/2022

NAPPI Change From Section 21 Product to SAHPRA Registered Product-Pfizer COVID-19 Vaccine.pdf

14/06/2022 Download
N006/2022

Notification of NAPPI Change from Section 21 Product to SAHPRA Registered Product – MSD Pty Ltd

26/04/2022 Download
N005/2022

Notification of NAPPI Change from Section 21 Product to SAHPRA Registered - Blinicyto

07/04/2022 Download
N004/2022

NAPPI Change in number of uses Vertice Healthcare

31/03/2022 Download
N003/2022

Notification of Change in Number of Uses SSM Mthembu

18/03/2022 Download
N037/2021

Notification of Change in number of uses - Perryhill

09/12/2021 Download
N036/2021

Notification of Change in number of uses - Johnson & Johnson

03/12/2021 Download
N035/2021

Notification of Change in number of uses - Perryhill International

04/11/2021 Download
N034/2021

Notification of Section 21 Products Changed to SAHPRA Registered Products - Lynparza Astra Zeneca Pharmaceuticals

04/11/2021 Download
N033/2021

Notification of Change in number of uses - Creatori Health

22/10/2021 Download